STOCK TITAN

Fractyl Health (GUTS) investors disclose 4.7% beneficial ownership stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Mithril-affiliated investment entities and their principals updated their ownership disclosure for Fractyl Health, Inc. common stock. Amendment No. 1 to their Schedule 13G reports that their aggregate percentage ownership has decreased, primarily because Fractyl Health sold additional shares of common stock.

Mithril and Mithril GP report beneficial ownership of 5,160,301 shares, representing 3.8% of the common stock outstanding. Mithril II, Mithril II GP and Mithril II UGP each report 1,251,900 shares, or 0.9% of the class. As an individual, Ajay Royan reports beneficial ownership of 6,460,102 shares, or 4.7%, including 30,000 stock options that are exercisable within 60 days and 17,901 shares held directly, with the remainder held through Mithril I and Mithril II. Peter Thiel reports shared beneficial ownership of 6,412,201 shares, also 4.7% of the class.

All percentages are based on 137,044,440 Fractyl Health common shares outstanding as of October 31, 2025, and each reporting person disclaims beneficial ownership except to the extent of their pecuniary interest.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: All such shares are held of record by Mithril I (as defined in Item 2(a) of the Original Schedule 13G (as defined below)). Mithril GP (as defined in Item 2(a) of the Original Schedule 13G) is the general partner of Mithril I and Mithril GP may be deemed to have shared voting, investment and dispositive power with respect to these securities. Ajay Royan is the authorized person of Mithril GP. Ajay Royan and Peter Thiel are the members of the investment committee of Mithril GP. The investment committee makes all investment decisions with respect to shares held by Mithril I and may be deemed to have shared voting, investment and dispositive power with respect to these securities. The percentage in Row 11 is based on 137,044,440 shares of the Issuer's common stock ("Common Stock") outstanding as of October 31, 2025 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended September 30, 2025, filed with the United States Securities and Exchange Commission (the "Commission") on November 12, 2025 (the "Form 10-Q").


SCHEDULE 13G




Comment for Type of Reporting Person: All such shares are held of record by Mithril I. Mithril GP is the general partner of Mithril I and Mithril GP may be deemed to have shared voting, investment and dispositive power with respect to these securities. Ajay Royan is the authorized person of Mithril GP. Ajay Royan and Peter Thiel are the members of the investment committee of Mithril GP. The investment committee makes all investment decisions with respect to shares held by Mithril I and may be deemed to have shared voting, investment and dispositive power with respect to these securities. The percentage in Row 11 is on 137,044,440 shares of Common Stock outstanding as of October 31, 2025, as set forth in the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: All such shares are held of record by Mithril II (as defined in Item 2(a) of the Original Schedule 13G). Mithril II UGP (as defined in Item 2(a) of the Original Schedule 13G) is the general partner of Mithril II GP (as defined in Item 2(a) of the Original Schedule 13G), which is the general partner of Mithril II, and each of Mithril II UGP and Mithril II GP may be deemed to have shared voting, investment, and dispositive power with respect to the shares held by Mithril II. Ajay Royan is the sole managing member of Mithril II UGP. Ajay Royan and Peter Thiel are the members of the investment committee established by Mithril II GP. The investment committee makes all investment decisions with respect to the shares held by Mithril II and may be deemed to have shared voting, investment and dispositive power with respect to such shares. The percentage in Row 11 is on 137,044,440 shares of Common Stock outstanding as of October 31, 2025, as set forth in the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: All such shares are held of record by Mithril II. Mithril II UGP is the general partner of Mithril II GP, which is the general partner of Mithril II, and each of Mithril II UGP and Mithril II GP may be deemed to have shared voting, investment, and dispositive power with respect to the shares held by Mithril II. Ajay Royan is the sole managing member of Mithril II UGP. Ajay Royan and Peter Thiel are the members of the investment committee established by Mithril II GP. The investment committee makes all investment decisions with respect to the shares held by Mithril II and may be deemed to have shared voting, investment and dispositive power with respect to such shares. The percentage in Row 11 is on 137,044,440 shares of Common Stock outstanding as of October 31, 2025, as set forth in the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: All such shares are held of record by Mithril II. Mithril II UGP is the general partner of Mithril II GP, which is the general partner of Mithril II, and each of Mithril II UGP and Mithril II GP may be deemed to have shared voting, investment, and dispositive power with respect to the shares held by Mithril II. Ajay Royan is the sole managing member of Mithril II UGP. Ajay Royan and Peter Thiel are the members of the investment committee established by Mithril II GP. The investment committee makes all investment decisions with respect to the shares held by Mithril II and may be deemed to have shared voting, investment and dispositive power with respect to such shares. The percentage in Row 11 is on 137,044,440 shares of Common Stock outstanding as of October 31, 2025, as set forth in the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: The shares reported in Rows 5 and 7 consist of (i) 30,000 shares subject to stock options granted to Ajay Royan in his capacity as a director of the Issuer that are exercisable as of the date of filing this Amendment (as defined below) or within 60 days thereafter and (ii) 17,901 shares of Common Stock that Ajay Royan holds directly. The shares reported in Rows 6 and 8 consist of (i) 5,160,301 shares held by Mithril I and (ii) 1,251,900 shares held by Mithril II. Mithril GP is the general partner of Mithril I and Mithril GP may be deemed to have shared voting, investment and dispositive power with respect to the securities held by Mithril I. Mithril II UGP is the general partner of Mithril II GP, which is the general partner of Mithril II, and each of Mithril II UGP and Mithril II GP may be deemed to have shared voting, investment and dispositive power with respect to the securities held by Mithril II. Ajay Royan is the authorized person of Mithril I GP and is the sole managing member of Mithril II UGP. Ajay Royan and Peter Thiel are the members of the investment committee of Mithril GP and the members of the investment committee established by Mithril II GP. Each of the investment committees makes all investment decisions with respect to the shares held by each of Mithril I and Mithril II, respectively, and may be deemed to have shared voting, investment and dispositive power with respect to the securities held by each of Mithril I and Mithril II. The percentage in Row 11 is on 137,044,440 shares of Common Stock outstanding as of October 31, 2025, as set forth in the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: The shares reported in Rows 6 and 8 consist of (i) 5,160,301 shares held by Mithril I and (ii) 1,251,900 shares held by Mithril II. Mithril GP is the general partner of Mithril I and Mithril GP may be deemed to have shared voting, investment and dispositive power with respect to the securities held by Mithril I. Mithril II UGP is the general partner of Mithril II GP, which is the general partner of Mithril II, and each of Mithril II UGP and Mithril II GP may be deemed to have shared voting, investment and dispositive power with respect to the securities held by Mithril II. Ajay Royan is the authorized person of Mithril I GP and is the sole managing member of Mithril II UGP. Ajay Royan and Peter Thiel are the members of the investment committee of Mithril GP and the members of the investment committee established by Mithril II GP. Each of the investment committees makes all investment decisions with respect to the shares held by each of Mithril I and Mithril II, respectively, and may be deemed to have shared voting, investment and dispositive power with respect to the securities held by each of Mithril I and Mithril II. The percentage in Row 11 is on 137,044,440 shares of Common Stock outstanding as of October 31, 2025, as set forth in the Form 10-Q.


SCHEDULE 13G



Mithril LP
Signature:/s/ Ajay Royan
Name/Title:Ajay Royan, Authorized Person of Mithril GP LP, the general partner of Mithril LP
Date:02/12/2026
Mithril GP LP
Signature:/s/ Ajay Royan
Name/Title:Ajay Royan, Authorized Person
Date:02/12/2026
Mithril II LP
Signature:/s/ Ajay Royan
Name/Title:Ajay Royan, Managing Member of Mithril II UGP LLC, the general partner of Mithril II GP LP, the general partner of Mithril II LP
Date:02/12/2026
Mithril II GP LP
Signature:/s/ Ajay Royan
Name/Title:Ajay Royan, Managing Member of Mithril II UGP LLC, the general partner of Mithril GP LP
Date:02/12/2026
Mithril II UGP LLC
Signature:/s/ Ajay Royan
Name/Title:Ajay Royan, Managing Member
Date:02/12/2026
Ajay Royan
Signature:/s/ Ajay Royan
Name/Title:Ajay Royan
Date:02/12/2026
Peter Thiel
Signature:/s/ Peter Thiel
Name/Title:Peter Thiel
Date:02/12/2026

FAQ

What ownership stake in Fractyl Health (GUTS) do the Mithril entities now report?

The Mithril entities collectively report beneficial ownership of 5,160,301 shares via Mithril I and 1,251,900 shares via Mithril II. These positions represent 3.8% and 0.9% of Fractyl Health’s common stock, respectively, based on 137,044,440 shares outstanding.

How much of Fractyl Health (GUTS) stock does Ajay Royan report owning?

Ajay Royan reports beneficial ownership of 6,460,102 shares of Fractyl Health common stock, representing 4.7% of the class. This includes 30,000 exercisable stock options, 17,901 shares held directly, and shares held through Mithril I and Mithril II.

What is Peter Thiel’s reported ownership in Fractyl Health (GUTS)?

Peter Thiel reports shared beneficial ownership of 6,412,201 shares of Fractyl Health common stock, equal to 4.7% of the outstanding shares. His reported stake arises through interests in Mithril I and Mithril II, which together hold those Fractyl Health shares.

Why did the reported ownership percentage in Fractyl Health (GUTS) decrease in this amendment?

The filing states that the decrease in aggregate ownership percentage results from Fractyl Health’s sale of additional common shares. This increased the total shares outstanding to 137,044,440 as of October 31, 2025, reducing the reporting persons’ percentage without a material change in their share count.

What type of filing is this for Fractyl Health (GUTS) and what does it update?

This is Amendment No. 1 to a Schedule 13G, which updates beneficial ownership information for large shareholders. It amends the original 13G filed November 13, 2024, restating current share counts and percentages after Fractyl Health issued additional common stock.

How many Fractyl Health (GUTS) shares are used to calculate the ownership percentages?

All reported ownership percentages are calculated using 137,044,440 shares of Fractyl Health common stock outstanding as of October 31, 2025. This outstanding share figure comes from the company’s Form 10-Q for the quarter ended September 30, 2025.
Fractyl Health

NASDAQ:GUTS

GUTS Rankings

GUTS Latest News

GUTS Latest SEC Filings

GUTS Stock Data

66.43M
151.28M
3.34%
53.84%
3.59%
Biotechnology
Surgical & Medical Instruments & Apparatus
Link
United States
BURLINGTON